The hippocampus is an important part of the limbic system in the human brain that has essential roles in spatial navigation and cognitive functions. It is still unknown how gene expression changes in single-cell in different spatial locations of the hippocampus of Parkinson’s disease. The purpose of this study was to analyze the gene expression features of single cells in different spatial locations of mouse hippocampus, and to explore the effects of gene expression regulation on learning and memory mechanisms. Here, we obtained 74 single-cell samples from different spatial locations in a mouse hippocampus through microdissection technology, and used single-cell RNA-sequencing and spatial transcriptome sequencing to visualize and quantify the single-cell transcriptome features of tissue sections. The results of differential expression analysis showed that the expression of Sv2b, Neurod6, Grp and Stk32b genes in a hippocampus single cell at different locations was significantly different, and the marker genes of CA1, CA3 and DG subregions were identified. The results of gene function enrichment analysis showed that the up-regulated differentially expressed genes Tubb2a, Eno1, Atp2b1, Plk2, Map4, Pex5l, Fibcd1 and Pdzd2 were mainly involved in neuron to neuron synapse, vesicle-mediated transport in synapse, calcium signaling pathway and neurodegenerative disease pathways, thus affecting learning and memory function. It revealed the transcriptome profile and heterogeneity of spatially located cells in the hippocampus of PD for the first time, and demonstrated that the impaired learning and memory ability of PD was affected by the synergistic effect of CA1 and CA3 subregions neuron genes. These results are crucial for understanding the pathological mechanism of the Parkinson’s disease and making precise treatment plans.
Circadian dysregulation of intestinal microbiota in Apoe−/− mice exerts a causal effect on ASCVD pathogenesis. Notably, B.coccoides attenuates ASCVD progression via gallic acid-mediated enhancement of colonic and aortic endothelial barrier functions.
Feeding patterns are emerging as critical regulators of cardiometabolic health; however, their impact on atherosclerotic cardiovascular disease (ASCVD) remains incompletely understood. Here, we demonstrate that feeding during the active phase (i.e., the dark/nighttime phase, when mice are active), either ad libitum (unrestricted access) or restricted to the nighttime (limited to the dark phase), confers significant protection against atherosclerosis in Apoe⁻/⁻ mice, compared to misaligned feeding during the inactive phase (restricted to the light phase). Multi–omics integration revealed that this atheroprotective effect is mediated by gut microbiota–driven modulation of bile acid (BA) metabolism, particularly involving taurolithocholic acid (TLCA), a potent agonist of the G protein–coupled bile acid receptor TGR5. Daytime feeding disrupted the relative abundance of BA–transforming taxa (e.g., Dubosiella, Clostridium) and downregulated key microbial genes (baiA, baiB, cbh, hdhA, and AMACR), leading to reduced TLCA biosynthesis. Despite unaltered hepatic expression of BAAT, FXR, and CYP7A1, compensatory upregulation of CYP7B1 was insufficient to restore TLCA levels. Consequently, impaired vascular TGR5 signaling promoted endothelial inflammation and reduced cholesterol efflux by downregulating ABCA1 expression, thereby facilitating plaque formation. These findings identify the microbiota–BA–TGR5 axis as a critical mediator of feeding rhythm–linked atheroprotection and underscore the therapeutic potential of chrono–nutrition in ASCVD prevention.
The feeding rhythm is a major temporal regulator of metabolic physiology, yet its impact on microbiome-derived functional traits relevant to cardiometabolic disease remains insufficiently understood. Our previous work demonstrated that ad libitum, daytime-restricted, and nighttime-restricted feeding produce markedly different atherosclerotic outcomes in Apoe − / − mice, indicating that the feeding rhythm acts as a modifiable determinant of atherogenic susceptibility. Here, we used shotgun metagenomics to profile risk-associated microbial functional modules—including Type III and Type VI secretion systems (T3SS/T6SS), siderophore-based iron acquisition pathways, quorum-sensing (QS) regulators, and antimicrobial resistance determinants—across feeding regimens. The feeding rhythm induced pronounced functional segregation independent of α -diversity, which was consistent with selective functional reprogramming rather than taxonomic restructuring. Daytime feeding, which is misaligned with the murine active phase, is associated with coordinated enrichment of the T3SS/T6SS, iron uptake, and QS pathways, forming a tightly interconnected “virulence–iron–QS–ARG” functional consortium. In contrast, circadian-aligned nighttime feeding resulted in attenuated virulence orientation and enhanced metabolic-cooperative signatures. Network inference further revealed strong coactivation of virulence secretion, iron mobilization, and QS modules under circadian misalignment. These findings show that the feeding rhythm modulates atherogenic susceptibility not only through host metabolism but also by remodeling gut microbial functional capacities, highlighting microbial functional ecology as an integral component of diet–host interactions.
Circadian rhythms in gut microbiota composition are crucial for metabolic function and disease progression, yet the diurnal oscillation patterns of gut microbiota in atherosclerotic cardiovascular disease (ASCVD) and their role in disease progression remain unknown. Here, we investigate gut bacterial dynamics in ApoE -/- mice within a day, and elucidated the dynamic changes in fecal microbiota composition and function differences among C57BL/6 and ApoE -/- mice with standard chow diet or high-fat, high-cholesterol diet under ad libitum conditions. Compared with C57BL/6 mice, ApoE -/- mice exhibit significant differences in fecal microbial composition. Rhythmic analysis showed that the dynamic changes in the composition and function of fecal microbiota in ApoE -/- mice were significantly different from those in C57BL/6 mice. We further found that the rhythmic strains ( Blautia Coccoides ) inhibit the progression of ASCVD by improving the intestinal and endothelial barrier function. Our findings demonstrate that diurnal oscillations in gut microbiota are closely related to the progression of ASCVD, and provide a new insight for microbial-targeted therapies for ASCVD.